ATP6V0C

Chr 16AD

ATPase H+ transporting V0 subunit c

Also known as: ATP6C, ATP6L, ATPL, EPEO3, VATL, VPPC, Vma3

The protein forms the proton-conducting pore of the V0 complex in vacuolar H+-ATPase, which acidifies intracellular compartments and maintains cellular pH homeostasis. Mutations cause autosomal dominant early-onset epilepsy with or without developmental delay, affecting the nervous system primarily in infancy or early childhood. The gene shows moderate constraint against loss-of-function variants (pLI 0.74, LOEUF 0.67), indicating that complete loss of function is somewhat selected against in the population.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismADLOEUF 0.671 OMIM phenotype
Clinical SummaryATP6V0C
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.74) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
53 unique Pathogenic / Likely Pathogenic· 41 VUS of 99 total submissions
📖
GeneReview available — ATP6V0C
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.67LOEUF
pLI 0.742
Z-score 1.96
OE 0.00 (0.000.67)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint
2.99Z-score
OE missense 0.19 (0.140.28)
21 obs / 108.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.00 (0.000.67)
00.351.4
Missense OE0.19 (0.140.28)
00.61.4
Synonymous OE1.17
01.21.6
LoF obs/exp: 0 / 4.5Missense obs/exp: 21 / 108.5Syn Z: -0.99
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongATP6V0C-related developmental disorderLOFAD
DN
0.7325th %ile
GOF
0.6833th %ile
LOF
0.3452th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

99 submitted variants in ClinVar

Classification Summary

Pathogenic39
Likely Pathogenic14
VUS41
Likely Benign2
39
Pathogenic
14
Likely Pathogenic
41
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
7
28
0
39
Likely Pathogenic
3
7
4
0
14
VUS
4
20
17
0
41
Likely Benign
0
0
0
2
2
Benign
0
0
0
0
0
Total113449296

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ATP6V0C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →